New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 1, 2014
09:12 EDTVRNT, HSP, MDCO, NVDA, STXS, DRTX, MRVL, RBCN, ARTX, MDR, CLNE, ISRG, UALOn The Fly: Pre-market Movers
HIGHER: Intuitive Surgical (ISRG), up 10% after announcing FDA clearance for new da Vinci Xi Surgical System... Clean Energy (CLNE), up 4% after beginning fueling at two stations, signing agreements... Durata Therapeutics (DRTX), up 8% after an FDA Committee voted in favor of its Dalvance injection for the treatment of certain acute bacterial skin and skin structure infections... Rubicon (RBCN), up 7.9% following upgrade at JPMorgan... United Continental (UAL), up 2.2% following upgrade at UBS... NVIDIA (NVDA), up 3% after upgrade at JMP Securities... Marvell (MRVL), up 4% after announcing it plans to appeal patent decision against it... Stereotaxis (STXS), up 12% after submitting 510 Premarket Notification with the FDA for the Vdrive Robotic system... Verint Systems (VRNT), up 5% after reporting earnings that beat expectations and providing a fiscal year outlook that also topped estimates. LOWER: Arotech (ARTX), down 11% after reporting fiscal year earnings and revenue that disappointed... The Medicines Company (MDCO), down 16% after court ruled the company failed to prove that Hospira's (HSP) generic Angiomax product infringed its patents... McDermott (MDR), down 5.8% after filing to sell 10M tangible equity units and saying that its first quarter results may differ "substantially" from the company's expectation.
News For UAL;RBCN;NVDA;ISRG;MRVL;MDCO;CLNE;DRTX;HSP;MDR;STXS;VRNT;ARTX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
December 10, 2014
05:39 EDTUALUnited Continental upgraded to Overweight from Underweight at Barclays
Barclays upgraded United Continental (UAL) two notches to Overweight from Underweight citing the benefits from lower oil prices. The firm raised its price target for shares to $76 from $52. The airliner closed yesterday down $1.73 to $62.52. Barclays also upgraded American Airlines (AAL) this morning to Overweight. Its top picks in the space are Spirit Airlines (SAVE), then American and United, followed by Delta Air Lines (DAL) and Southwest (LUV). It now has Overweight ratings on all four major U.S. airlines.
December 9, 2014
13:08 EDTHSPMerck may have paid $2B-$3B too much for Cubist, analyst says
Subscribe for More Information
09:21 EDTUALOn The Fly: Pre-market Movers
UP AFTER EARNINGS: AutoZone (AZO), up 3.8%... Burlington Stores (BURL), up 3.3%. ALSO HIGHER: bluebird bio (BLUE), up 56.5% after price target raised at Piper Jaffray and SunTrust... Camtek (CAMT), up 6.7% after being awarded a $2.8M order from a semiconductor manufacturer... PDC Energy (PDCE), up 5.8% after providing fiscal 2015 production guidance... Mast Therapeutics (MSTX), up 3.1% after reporting that it will begin recruiting patients for MST-188 study in first half of fiscal 2015... Idera Pharmaceuticals (IDRA), up 1.4% after announcing data for its lead product candidate, IMO-8400. DOWN AFTER EARNINGS: UTi Worldwide (UTIW), down 10.8%... CONN'S (CONN), down 35.9% after reporting third quarter results, withdrawing fiscal 2015 guidance, stating that there is no timetable set for completion of strategic alternatives, and announcing the departure of its CFO. ALSO LOWER: Apple (AAPL), down 1.6% after Pacific Crest says that weak iPad demand could cause Apple to miss estimates and following a Wall Street Journal report that a judge denied Apple's efforts to throw out iPod pricing lawsuit... Allied Nevada Gold (ANV), down 30.1% after announcing pricing of common stock and warrant offering... United Continental (UAL), down 2.7% after reporting November traffic.
08:23 EDTHSPMerck has 'no way out' of Cubist deal after court decision, says Leerink
Subscribe for More Information
08:12 EDTHSPMerck still sees Cubist acquisition neutral to modestly accretive to 2015 EPS
Merck (MRK) issued the following statement regarding the decision of the U.S. District Court for the District of Delaware. The decision, which upheld the patent for CUBICIN that expires on June 15, 2016 and invalidated four others, is subject to appeal. The company continues to believe the acquisition of Cubist (CBST) will create strong fundamental value for Merckís shareholders. The combined strength of both companies will provide both incremental and long-term value, and Merck expects the transaction to add more than $1B of revenue to its 2015 base, with strong growth potential thereafter. The courtís decision does not change Merckís expectation that the transaction will be neutral to modestly accretive to 2015 non-GAAP EPS. The company also continues to expect that the transaction will contribute mid-single digit accretion on a percentage basis to non-GAAP EPS in 2016, and will continue to be accretive thereafter.
December 8, 2014
19:00 EDTHSPCubist CEO says Cubicin patent ruling will not affect Merck transaction
Subscribe for More Information
18:24 EDTHSPOn The Fly: After Hours Movers
Subscribe for More Information
18:00 EDTHSPCubist loses bid to stop Hospira's generic Cubicin after 2016, Bloomberg says
Cubist's (CBST) patent for Cubicin that expires in June 2016 upheld by judge, Bloomberg added. Note that this morning Merck (MRK) and Cubist Pharmaceuticals announced that the companies have entered into a definitive agreement under which Merck will acquire Cubist for $102 per share in cash.
17:54 EDTHSPFour Cubist Cubicin patents invalidated as Hospira wins ruling, Bloomberg says
Subscribe for More Information
17:30 EDTHSPMerck shares lower after reports of judge decision in Cubist/Hospira case
Subscribe for More Information
17:03 EDTHSPJudge may have found in favor of Hospira in Cubist case,CNBC's Meg Tirrell says
CNBC's Meg Tirrell said in a tweet: "Whoa. $CBST Hospira decision out -- "appears judge may have found in favor of Hospira on several points," ISI's @MarkSchoenebaum says." Reference Link
16:26 EDTUALUnited Continental November consolidated traffic down 0.3%
Subscribe for More Information
12:25 EDTMDCOAntibiotic makers rise after Merck agrees to buy Cubist
Subscribe for More Information
10:11 EDTMDCOHigh option volume stocks
Subscribe for More Information
10:00 EDTCLNEOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
08:21 EDTHSPMerck says looked at all risks, including patent litgation, before Cubist deal
Subscribe for More Information
05:42 EDTCLNEClean Energy downgraded to Hold from Buy at Ascendiant
Subscribe for More Information
December 4, 2014
10:18 EDTUALAirline stocks lifted following JPMorgan valuation call
Subscribe for More Information
08:17 EDTVRNTVerint Systems should be bought on weakness, says Oppenheimer
Subscribe for More Information
07:26 EDTUALJPMorgan says Airlines more attractive today than two months ago
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use